image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Health

November 2010

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 743p
Synergy has announced that earnings for the six months to 26 September are expected to be in line with expectations. The margin growth seen in Q1 has continued into Q2, while there has been further revenue growth in the sterilisation and decontamination divisions, although this has slightly been offset by zero growth in revenues from the linen side and by the wind-down of its non-core businesses. The bid pipeline is improving and new contract wins worth £60m have been added to the order book, taking the total to c. £860m. The shares have had a strong run in the past six months and are close to several brokers’ price targets. Given that the gain since we added them to the Trader Portfolio at 2 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe